Tuesday, November 14, 2023
Print Current Session:
![]() |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
|
|
SESSION 10 SCHEDULE | |
7:50 AM - 7:55 AM | Update On International Variations In Carotid Stenosis Treatment Within Countries And Between Countries Is Huge Despite All The RCTs On Which They Are Based Being The Same: What Are The Implications |
Presenter(s):Maarit Venermo, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
7:56 AM - 8:01 AM | Current Optimal Treatment For Carotid Artery Dissection: When Best Medical Therapy (BMT), When Open Surgery, When Carotid Stenting (CAS) With Proximal Embolic Protection |
Presenter(s):Felice Pecoraro, MD Location: Grand Ballroom West, 3rd Floor |
|
8:02 AM - 8:07 AM | Intracranial Imaging For Strokes With A Newly Developed Imaging Platform Using Artificial Intelligence To Integrate All Forms Of Imaging To Facilitate Patient Care: The VIZ.ai System |
Presenter(s):Allan L. Brook, MD Location: Grand Ballroom West, 3rd Floor |
|
8:08 AM - 8:13 AM | Value Of Advanced Imaging In The Diagnosis And Treatment Of Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA): How Are They Best Treated: When Conservatively; When Invasively By CEA; By CAS |
Presenter(s):Christos D. Liapis, MD Location: Grand Ballroom West, 3rd Floor |
|
8:14 AM - 8:19 AM | What Is Carotid Near Occlusion: When And How Is It Best Treated Currently: Conservatively, CEA, CAS In Symptomatic Patients: In Asymptomatic Patients |
Presenter(s):Weiguo Fu, MD Location: Grand Ballroom West, 3rd Floor |
|
8:20 AM - 8:26 AM | Panel Discussion |
8:26 AM - 8:31 AM | DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Be Reimbursed |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom West, 3rd Floor |
|
8:32 AM - 8:37 AM | DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
8:38 AM - 8:43 AM | DEBATE: Both Views Are Wrong: Severe Carotid Stenosis Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So <5% Of ACS Patients Should Be Treated Invasively |
Presenter(s):Robert W. Chang, MD Location: Grand Ballroom West, 3rd Floor |
|
DIFFERING VIEWS ON CAROTID SCREENING | |
8:44 AM - 8:49 AM | A Tribute To George S. Lavenson, MD (1932-2023) And His Case For Widespread Carotid Screening |
Presenter(s):Benjamin W. Starnes, MD Location: Grand Ballroom West, 3rd Floor |
|
8:50 AM - 8:55 AM | The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom West, 3rd Floor |
|
8:56 AM - 9:01 AM | Screening For ACS And Common Femoral Artery Disease: How Can It Guide Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques |
Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor |
|
9:02 AM - 9:07 AM | What Are The Effects Of A Minor Stroke With Apparent Full Recovery: Minor Strokes Are By No Means Minor: Why Is This Important In Evaluating The Conclusions Of RCTs |
Presenter(s):Emmanuel M. Houdart, MD Location: Grand Ballroom West, 3rd Floor |
|
9:08 AM - 9:15 AM | Panel Discussion |
9:15 AM - 9:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 10 | |
previous | next |